Clinical studies recruiting near Changchun

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · The First Hospital of Jilin University · Eli Lilly and Company · NCT07218380 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · The First Hospital of Jilin University · Daiichi Sankyo · NCT07022483 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · The First Hospital of Jilin University-Hematology ( Site 203 · Merck Sharp & Dohme LLC · NCT06136559 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Jilin University Second Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Jilin Province Tumor Hospital · Pfizer · NCT06758401 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · First Hospital of Jilin University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · The First Hospital of Jilin University · Jinling Hospital, China · NCT06118840 Application of Biomarkers in Neurological Diseases
Phase N/A · First Hospital of Jilin University · Yi Yang · NCT05881226 Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantat
Phase 2 · The First Hospital of Jilin University · Yehui Tan · NCT07047183 A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Phase 2 · Jilin Cancer Hospital · Abbisko Therapeutics Co, Ltd · NCT06668103 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Jilin Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The First Hospital of Jilin University · Shanghai Henlius Biotech · NCT07160335 The Chinese Familial Alzheimer's Network
Phase N/A · China-Japan friendship Hospital of Jilin university · Capital Medical University · NCT03657732 Randomization of Single vs Multiple Arterial Grafts
NA · Jilin Heart Hospital · Weill Medical College of Cornell University · NCT03217006 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The First Bethune Hospital of Jilin University · Amgen · NCT07037433 Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Brea
Phase 2/Phase 3 · The Second Norman Bethune Hospital of Jilin Univer · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05744687 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · The First Hospital of Jilin University · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · The Second Hospital of Jilin University · Bristol-Myers Squibb · NCT07361289 A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Phase 1 · Changchun · SCG Cell Therapy Pte. Ltd. · NCT06617000 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Jilin Cancer Hospital · Eli Lilly and Company · NCT06890598 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Jilin Cancer Hospital/Medical Oncology Department · Turning Point Therapeutics, Inc. · NCT03093116 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · The First Hospital of Jilin University · Eli Lilly and Company · NCT07369011 A Phase IIII Study of AL8326 in Small Cell Lung Cancer
Phase 3 · JILIN Cancer Hospital · Advenchen Laboratories Nanjing Ltd. · NCT06247605 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Jilin Cancer Hospital · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · The First Hospital of Jilin University · Gilead Sciences · NCT06051617 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Phase 1/Phase 2 · Research site015 · Allist Pharmaceuticals, Inc. · NCT05276726 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Phase 1/Phase 2 · The first hospital of jilin university · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent
Phase 3 · The first hospital of Jilin University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07003074

Look up another city

Look up another condition